SciTech SDP

SciTech Development is a Specialty Pharmaceutical Company dedicated to advancing breakthrough cancer treatments. SciTech’s innovations and pipeline will impact our mission to develop cost-effective therapeutics that deliver transformative clinical outcomes.

SCITECH DEVELOPMENT LLC

Introducing Our Revolutionary New Drug Delivery Platform (SDP) and Lead Cancer Drug Candidate ST-001 nanoFenretinide. 

●	Our proprietary Drug Delivery Platform, called SDP, has enormous potential to develop and deliver new and better drugs for incurable cancers.
●	ST-001-nanoFenretinide is our first, patented drug, that combines SDP and the drug fenretinide as a broadly applicable anticancer drug.
●	Fenretinide presents a low-risk scenario as it has been shown to be safe and effective in both children and adults in previous clinical trials. 
●	ST-001 is clinical trial ready!